Recent publications
-
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
Part of Immunity, Inflammation and Disease, 2022.
DOI for Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology Download full text (pdf) of Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
-
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
Part of Vaccines, 2022.
DOI for Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines Download full text (pdf) of Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
-
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
Part of Journal for ImmunoTherapy of Cancer, 2022.
DOI for Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials Download full text (pdf) of Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
Part of Journal of Internal Medicine, p. 72-80, 2022.
DOI for Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19 Download full text (pdf) of Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
-
Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
Part of Pharmaceutics, 2022.
DOI for Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody Download full text (pdf) of Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
-
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
Part of Lancet. Infectious diseases (Print), p. 943-945, 2022.
-
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
Part of JAMA Network Open, 2022.
DOI for Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab Download full text (pdf) of Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab
-
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
Part of Journal of Translational Medicine, 2022.
DOI for Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination Download full text (pdf) of Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
-
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
Part of Clinical & Translational Immunology (CTI), 2022.
DOI for Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time Download full text (pdf) of Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
-
A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
Part of NEUROTHERAPEUTICS, p. 1588-1602, 2022.
DOI for A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice Download full text (pdf) of A Brain-Targeting Bispecific-Multivalent Antibody Clears Soluble Amyloid-Beta Aggregates in Alzheimer's Disease Mice
-
Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
Part of Alzheimer's Research & Therapy, 2022.
DOI for Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease Download full text (pdf) of Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
-
Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
Part of Scientific Reports, 2022.
DOI for Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3 Download full text (pdf) of Introducing or removing heparan sulfate binding sites does not alter brain uptake of the blood-brain barrier shuttle scFv8D3
-
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Part of PLOS ONE, 2022.
DOI for SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection Download full text (pdf) of SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
-
An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
Part of Advanced Therapeutics, 2022.
DOI for An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies Download full text (pdf) of An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
-
Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
Part of International Immunopharmacology, 2021.
DOI for Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients Download full text (pdf) of Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
-
Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
Part of Molecular Imaging and Biology, 2021.
DOI for Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease Download full text (pdf) of Pinpointing Brain TREM2 Levels in Two Mouse Models of Alzheimer's Disease
-
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
Part of Journal of the American Medical Association (JAMA), p. 2015-2016, 2021.
-
Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells
Part of New Biotechnology, p. 9-19, 2021.
DOI for Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells Download full text (pdf) of Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells
-
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
Part of EBioMedicine, 2021.
DOI for Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2 Download full text (pdf) of Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
-
Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
Part of PLOS ONE, 2021.
DOI for Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations Download full text (pdf) of Single-cell RNAseq and longitudinal proteomic analysis of a novel semi-spontaneous urothelial cancer model reveals tumor cell heterogeneity and pretumoral urine protein alterations
-
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
Part of PLOS ONE, 2021.
DOI for An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses Download full text (pdf) of An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
-
Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
Part of Translational Neurodegeneration, 2021.
DOI for Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta Download full text (pdf) of Novel multivalent design of a monoclonal antibody improves binding strength to soluble aggregates of amyloid beta
-
Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
Part of Theranostics, p. 789-804, 2021.
DOI for Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain Download full text (pdf) of Enhanced neprilysin-mediated degradation of hippocampal A beta 42 with a somatostatin peptide that enters the brain
-
Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
Part of Journal of Pathology, p. 243-256, 2021.
DOI for Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer Download full text (pdf) of Infiltration of NK and plasma cells is associated with a distinct immune subset in non‐small cell lung cancer
-
Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
Part of ACS Chemical Neuroscience, p. 2529-2541, 2021.
DOI for Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide Download full text (pdf) of Wide-Ranging Effects on the Brain Proteome in a Transgenic Mouse Model of Alzheimer's Disease Following Treatment with a Brain-Targeting Somatostatin Peptide
-
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade
Part of Cancers, 2021.
DOI for Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade Download full text (pdf) of Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade
-
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Part of Oncoimmunology, 2020.
DOI for Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy Download full text (pdf) of Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
-
Flodvåg av långtidssjuka covid-19-patienter väntar
Part of Dagens Nyheter, p. 5-5, 2020.
-
Tumor localized agonistic anti-CD40 therapy and beyond
Part of Expert Opinion on Biological Therapy, p. 215-217, 2020.
DOI for Tumor localized agonistic anti-CD40 therapy and beyond
-
Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
Part of The FASEB Journal, p. 13272-13283, 2020.
DOI for Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle. Download full text (pdf) of Brain delivery of biologics using a cross-species reactive transferrin receptor 1 VNAR shuttle.
-
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
Part of Toxicology reports, p. 768-771, 2020.
DOI for Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention Download full text (pdf) of Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention
-
BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling
Part of Molecular Oncology, p. 202-211, 2019.
DOI for BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling Download full text (pdf) of BCG-induced cytokine release in bladder cancer cells is regulated by Ca2+ signaling
-
Formation of Immune Complexes with a Tetanus-Derived B Cell Epitope Boosts Human T Cell Responses to Covalently Linked Peptides in an Ex Vivo Blood Loop System
Part of Journal of Immunology, p. 87-97, 2018.
-
[F-18]Tetrazine-trans-cyclooctene mediated labelling of antibodies for PET imaging of amyloid-beta
Part of European Journal of Nuclear Medicine and Molecular Imaging, p. S643-S643, 2018.
-
Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
Part of Alzheimer's Research & Therapy, 2018.
DOI for Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody Download full text (pdf) of Efficient clearence of A beta protofibrils in A beta PP-transgenic mice treated with a brain-penetrating bifunctional antibody
-
Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
Part of Journal of Nuclear Medicine, p. 1885-1891, 2018.
DOI for Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition Download full text (pdf) of Antibody-Based In Vivo PET Imaging Detects Amyloid-beta Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition
-
Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics
Part of International Immunopharmacology, p. 1-11, 2018.
DOI for Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics Download full text (pdf) of Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics
-
Blood-Brain Barrier Integrity in a Mouse Model of Alzheimer’s Disease With or Without Acute 3D6 Immunotherapy
Part of Neuropharmacology, p. 1-9, 2018.
DOI for Blood-Brain Barrier Integrity in a Mouse Model of Alzheimer’s Disease With or Without Acute 3D6 Immunotherapy Download full text (pdf) of Blood-Brain Barrier Integrity in a Mouse Model of Alzheimer’s Disease With or Without Acute 3D6 Immunotherapy
-
Antibody-based PET radioligands for imaging of amyloid-beta protofibrils
Part of Journal of Cerebral Blood Flow and Metabolism, p. 84-84, 2017.
-
Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
Part of Theranostics, p. 308-318, 2017.
DOI for Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor Download full text (pdf) of Bivalent Brain Shuttle Increases Antibody Uptake by Monovalent Binding to the Transferrin Receptor
-
A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
Part of NeuroImage, p. 55-63, 2017.
DOI for A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging Download full text (pdf) of A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging
-
Evolution of the p53-MDM2 pathway
Part of BMC Evolutionary Biology, 2017.
DOI for Evolution of the p53-MDM2 pathway Download full text (pdf) of Evolution of the p53-MDM2 pathway
-
Emergence and evolution of an interaction between intrinsically disordered proteins
Part of eLIFE, 2017.
DOI for Emergence and evolution of an interaction between intrinsically disordered proteins Download full text (pdf) of Emergence and evolution of an interaction between intrinsically disordered proteins
-
Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
Part of Journal of Translational Medicine, 2017.
DOI for Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients Download full text (pdf) of Adenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
-
Adenovirus-mediated CD40L gene transfer increases teffector/tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients
Part of Scandinavian Journal of Immunology, p. 337-337, 2017.
-
Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
Part of European Journal of Immunology, p. 385-393, 2017.